| Micro-channel |
 |
|
|
|
|
|
| |
| The market of large scale restriction of infusion antibiotics in China will be challenged |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-8-24 11:22:16 Number Browse：762 |
| |
Medical network on August 24 - recently, according to the communist party of China (fuyang municipal party committee, the funan county in anhui province such as zhu village town liu village clinic Wang Xiulei six village doctor, because not infusion and working funds 76000 yuan reward.
At first glance, feel incredible, no fluids have a reward, now only one, if this approach is to promote, so large infusion and transfusion forms in the majority of antibiotic market, will face severe challenges.
▍ nationwide large area limits infusion
In recent years, restrictions on infusion of fluid have been introduced everywhere, from big hospitals to small hospitals, and nationwide restrictions on infusion movement have been sounded.
At present, 14 provinces, including guangdong, zhejiang, jiangsu, anhui and jiangxi, have explicitly restricted the outpatient infusion.And guangdong province, the big pharma province, took the lead in stopping the emergency infusion.
On July 25, the official website of the guangdong provincial health and family planning commission published a notice on strengthening the management of intravenous administration of primary medical and health institutions.Notice for the family planning administrative department of public health and basic medical and health institutions at various levels of venous transfusion management work deployment, and clearly put forward the 53 kinds of diseases, emergency door does not need intravenous therapy.
From last year, gansu and shaanxi provincial health and family planning commission began to restrict the transfusion of the health room, and some areas even banned the intravenous fluids from the village.City of jiangsu province who planning commission is required village clinics are not allowed to purchase azlocillin, amoxicillin clavulanic acid, cefotaxime and cefixime, cefazolin oxime, azithromycin injection and levofloxacin injection of antibiotics.
For example, in the case of anhui province, there is a precedent to reward tens of thousands of yuan for the lack of infusion in the village health room. In order to better limit the infusion, will other regional departments follow suit?
Grassroots medical institutions and clinics is generally believed that the abuse of the infusion, transfusion of the most serious place especially antibiotics, if this approach is widely used in basic, for large infusion, one can imagine the antibiotic market impact.
▍ limit infusion impact on industry
Restricting the infusion of fluids, especially the antibiotics and traditional Chinese medicine injection production enterprises, has inevitable impact.
First look at the big infusion.According to incomplete statistics, three of every 10 outpatient patients in China have carried out transfusion.Since 2016, the outpatient service has been halted all over the country.The impact is that the number of hospital major infusion products in 2016 dropped significantly.
(source: zhongkang CMH)
China is a large country with antibiotics. The annual sales volume of antibiotics in China is up to 138 grams, 10 times that of the United States.There is industry analysis that the misuse of antibiotics is one of the reasons for the rapid growth of medical expenses.
From the perspective of data statistics, after the implementation of restrictions and restrictions on infusion, antibiotics products from the previous top 10 in the pharmaceutical market, to gradually exit the top 10 queues.In 2016, the list of the top 10 market share was completely out of sight.
(source: zhongkang CMH)
As the policy of restricting the outpatient service and the basic infusion of infusion is falling to the ground, everyone is panicking that when it will fall to its own area.After all, it is a huge shock to market sales of related drug companies to limit the transfusion of outpatient treatment in large hospitals and to restrict the infusion of the basic infusion. The above data can be reflected.
The personage inside course of study thinks, accompanied by restricting fluids, resistance to limit, health insurance fees, etc. Series of reform, related industry has experienced a big reshuffle, many small and medium enterprises or survival unsustainable forced to shut down, or be acquired.In the future, China is likely to have five or six large infusion companies.
|
| |
Previous article：These 39 medicines will be subject to a big bargain.
Next article：Always be check!!!These tablets are the most dangerous
|
| |
|
|
